Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
Publications
1 records shown · first 60CD163 is a predictive biomarker for prognosis of classical Hodgkin's lymphoma in Saudi patients.
PMID 31289681 | PMCID PMC6535641 | DOI 10.3892/mco.2019.1850 · Molecular and clinical oncology · 2019 · 4 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| variant | rs75608120 | “Among the studied CD163 SNPs, rs75608120 exhibited a significant correlation with the DR rate of CHL patients, but not with OS.” | 0.90 | hgvs_regex_v1 |
| gene | CD163 | “CD163 is a predictive biomarker for prognosis of classical Hodgkin's lymphoma in Saudi patients.” | 0.98 | hgnc_dict_v1 |
| phenotype | lymphoma | “CD163 is a predictive biomarker for prognosis of classical Hodgkin's lymphoma in Saudi patients.” | 0.98 | phenotype_alias_lexicon_v2 |
| population | Saudi Arabia | “CD163 is a predictive biomarker for prognosis of classical Hodgkin's lymphoma in Saudi patients. The aim of the present retrospective case-control study was to establish a gene expression profile of a specific biomarker for classical HL (CHL) in order to predict the outcome and survival of CHL patients in Saudi Arabia. Genotyping of selected SNPs of this antigen was performed for 100 CHL cases and controls.” | 0.95 | saudi_context_rules_v1 |